Search

Molecular Diagnostics Point of Care Market Size, Major Players, Revenue Analysis, 2021–2032 The Global Molecular Diagnostics Point of Care Market is projected to reach USD 4.84 billion in 2027 To know more about the report, visit @ https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

Brain Tumor Diagnosis and Therapeutics Market Size to Reach USD 5.30 Billion by 2032 | Key Trends & Forecasts Global brain tumor diagnosis and therapeutics market is undergoing accelerated transformation driven by technological breakthroughs in imaging, molecular diagnostics, and personalized treatment approaches. Valued at USD 2.66 billion in 2024, the market is projected to reach USD 2.95 billion in 2025 and expand to USD 5.30 billion by 2032, exhibiting an impressive CAGR of 10.6%. Rising disease awareness, growing investments in advanced neurosurgical facilities, and rapid adoption of integrated multimodal therapies are reshaping the landscape of neuro-oncology worldwide. Access the full report with detailed insights, market forecasts, and competitive analysis at 24LifeSciences. https://www.24lifesciences.com/brain-tumor-diagnosis-and-therapeutics-market-9371

Meningitis Diagnosis and Treatment Market Size to Reach USD 5.12 Billion by 2032 | Key Trends & Forecasts Global meningitis diagnosis and treatment market is undergoing a pivotal transformation driven by heightened infectious disease vigilance, rapid adoption of molecular diagnostics, and expanding access to emergency clinical care. Valued at USD 3.02 billion in 2024, the market is projected to rise to USD 3.26 billion in 2025 and further reach USD 5.12 billion by 2032, growing at a CAGR of 6.8%. This reflects the global push toward faster pathogen detection, improved treatment regimens, and stronger public health infrastructure. Access the complete dataset, competitive insights, and expert forecasts at 24LifeSciences. https://www.24lifesciences.com/meningitis-diagnosis-and-treatment-market-9528